| # | Company | Location | Employees | Total Funding | Last Round | Last Funded |
|---|---|---|---|---|---|---|
| 1 |
Parse Biosciences
Parse Biosciences is a biotechnology startup company that develops single-cell s…
|
Seattle | 101 - 250 | $100.0M | Series C | 2023-12-14 |
| 2 |
SOPHiA GENETICS
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professi…
|
Boston | 251 - 500 | $265.2M | Post Ipo Debt | 2024-05-02 |
| 3 |
Helix
Helix is a population genomics company that is working to advance genomics resea…
|
San Mateo | 101 - 250 | $403.0M | Series C | 2021-06-03 |
| 4 |
Medra AI
Medra AI develops an autonomous scientific experimentation platform that combine…
|
San Francisco | 11 - 50 | $63.0M | Series A | 2025-12-11 |
| 5 |
ShanX Medtech
ShanX Medtech is a medical diagnostics company that offers rapid in vitro diagno…
|
Eindhoven | 11 - 50 | $17.5M | Seed | 2026-01-07 |
| 6 |
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology and laboratory equipment company tha…
|
Waltham | c 10001 max | $19.8B | Post Ipo Debt | 2026-02-09 |
| 7 |
BostonGene
BostonGene is a biomedical software company for advanced patient analysis and pe…
|
Waltham | 251 - 500 | $200.0M | Series B | 2022-04-06 |
| 8 |
BIOMAKERS
BIOMAKERS is a biotechnology research company that offers molecular testing and …
|
Recoleta | 101 - 250 | $10.4M | Series A | 2026-01-12 |
| 9 |
Envisagenics
Envisagenics reduce the complexity of biomedical data to accelerate the developm…
|
Long Island City | 11 - 50 | $52.1M | Series B | 2024-06-04 |
| 10 |
Mission Bio
Mission Bio develops only single-cell multi-omics platform integrating genotype …
|
San Francisco | 101 - 250 | $150.9M | Series Unknown | 2025-08-05 |
| 11 |
Omniscient Neurotechnology
Omniscient develops AI and data-driven solutions to improve treatment for brain …
|
Sydney | 51 - 100 | $57.2M | Series D | 2026-01-16 |
| 12 |
Basecamp Research
Basecamp Research leverages their unprecedented knowledge of the natural world t…
|
London | 11 - 50 | $79.9M | Series B | 2024-10-09 |
| 13 |
DNAnexus
DNAnexus develops a cloud platform and global network designed for scientific co…
|
Mountain View | 101 - 250 | $472.6M | Series H | 2022-03-08 |
| 14 |
Unlearn.AI
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable s…
|
San Francisco | 51 - 100 | $134.8M | Series C | 2024-02-08 |
| 15 |
TruDiagnostic
TruDiagnostic is a biodata research company that offers epigenetic testing and r…
|
Lexington | 51 - 100 | $321K | Grant | 2025-09-19 |
| 16 |
Pluto Biosciences
Pluto Biosciences develops a collaborative life sciences platform for biological…
|
Denver | 11 - 50 | $8.3M | Seed | 2025-05-13 |
| 17 |
Locus Fermentation Solutions
Leading the ESG revolution by fermenting award-winning, green ingredients to the…
|
Solon | 51 - 100 | $192.0M | Convertible Note | 2025-12-10 |
| 18 |
LatchBio
LatchBio is a biotech research company that provides code-free platform for the …
|
San Francisco | 11 - 50 | $33.2M | Series A | 2022-06-02 |
| 19 |
Genialis
Genialis is a computational precision medicines company that develops a clinical…
|
Boston | 11 - 50 | $15.5M | Series A | 2023-03-29 |
| 20 |
Spiber
Spiber is a biotech company that utilizes microbial fermentation technology to d…
|
Tsuruoka | 251 - 500 | $976.1M | Private Equity | 2024-04-12 |
| 21 |
EvolutionaryScale
EvolutionaryScale is a developer of biological artificial intelligence models fo…
|
New York | 11 - 50 | $142.0M | Seed | 2024-06-25 |
| 22 |
Biotia
Biotia is a health tech startup offering AI-based solutions to diagnose and cont…
|
Brooklyn | 1 - 10 | $10.7M | Grant | 2025-06-17 |
| 23 |
Network Bio
Network Bio's biomedical data for AI-enabled precision medicine
|
New York | 11 - 50 | $19.5M | Seed | 2025-02-27 |
| 24 |
Actio Biosciences
Actio Biosciences is a research center that develops drugs for rare diseases.
|
San Diego | 11 - 50 | $121.0M | Series B | 2025-06-18 |
| 25 |
datma
datma develops a cloud based infrastructure for the ingestion, harmonization, an…
|
Beaverton | 11 - 50 | $21.2M | Series Unknown | 2022-06-15 |
| 26 |
Canomiks
Canomiks' genomics, bioinformatics, and AI-based Product Superiority Platform he…
|
Rochester | 1 - 10 | $1.4M | Grant | 2024-06-18 |
| 27 |
NuCicer
NuCicer offers high-protein chickpea ingredients with added value in the agri-fo…
|
Davis | 11 - 50 | $32.3M | Series A | 2025-07-30 |
| 28 |
Inflammatix
Inflammatix develops rapid immune system diagnostics to improve patient care and…
|
Burlingame | 51 - 100 | $194.8M | Series E | 2024-09-12 |
| 29 |
310.ai
At 310 AI, our aim is to build the generative AI engine that will make programma…
|
San Francisco | 11 - 50 | $3.8M | Seed | 2023-01-01 |
| 30 |
Biome Makers
Biome Makers develops neural biocomputing applications that enable sustainable a…
|
West Sacramento | 51 - 100 | $25.0M | Non Equity Assistance | 2024-08-22 |
| 31 |
InterAx Biotech Ltd
Connecting biology, mathematical modelling and AI to accelerate drug discovery.
|
Villigen | 11 - 50 | $8.0M | Grant | 2019-09-25 |
| 32 |
Polaris Genomics
Polaris Genomics identifies genomic biomarkers to support the development of psy…
|
Gaithersburg | 11 - 50 | $5.5M | Debt Financing | 2025-08-26 |
| 33 |
PRCXI Biotechnology
PRCXI Biotechnology is a biotech company that focuses on analytical instruments,…
|
Suzhou | 101 - 250 | $55.0M | Series A | 2025-12-31 |
| 34 |
Mariana Oncology
Mariana Oncology is a biotechnology research industry.
|
Watertown | 11 - 50 | $250.0M | Series B | 2023-09-07 |
| 35 |
Salus BioMed
Salus BioMed is an innovative biomedical company that specializes in developing …
|
Shenzhen | 51 - 100 | $20.9M | Series B | 2025-10-09 |
| 36 |
Epistemic AI
Knowledge discovery platform for the life sciences,
|
Westport | 11 - 50 | $15.9M | Corporate Round | 2025-01-13 |
| 37 |
Allelica
Allelica is a genomics software company driving the transition of Polygenic Risk…
|
New York | 11 - 50 | $1.8M | Seed | 2021-03-05 |
| 38 |
Genapsys
Transform the human condition by building a scalable, affordable genomic sequenc…
|
Redwood City | 51 - 100 | $319.0M | Series D | 2021-05-27 |
| 39 |
Liberate Bio
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, …
|
Boston | 11 - 50 | $31.0M | Seed | 2025-10-15 |
| 40 |
Personal Genome Diagnostics
Personal Genome Diagnostics develops a patient-specific analysis of the cancer g…
|
Baltimore | 101 - 250 | $244.7M | Series C | 2021-02-10 |
| 41 |
Phylagen
Phylagen is digitizing the global microbiome to create a more transparent world
|
San Francisco | 11 - 50 | $14.0M | Series A | 2019-02-14 |
| 42 |
omica.ai
Omica turns real-world clinical data into structured training infrastructure for…
|
New York | 1 - 10 | $1.0M | Pre Seed | 2024-02-16 |
| 43 |
Aitia
Leader in the application of Causal AI and Digital Twins to discover the next ge…
|
Somerville | 11 - 50 | $77.3M | Series D | 2019-07-09 |
| 44 |
Lifebit
Lifebit CloudOS is the intelligent genomics platform that is the industry standa…
|
London | 51 - 100 | $70.6M | Series B | 2021-09-28 |
| 45 |
Cambrium
Cambrium is engineering biology to create high-performance proteins.
|
Berlin | 11 - 50 | $8.5M | Seed | 2024-06-20 |
| 46 |
Helex
Enabling Safer Gene Editing
|
New York | 11 - 50 | $4.6M | Seed | 2025-10-30 |
| 47 |
Syapse
Syapse is a real-world evidence company dedicated to extinguishing the fear and …
|
San Francisco | 51 - 100 | $222.6M | Series Unknown | 2022-07-27 |
| 48 |
TRex Bio
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic b…
|
South San Francisco | 11 - 50 | $169.0M | Series B | 2024-11-13 |
| 49 |
FOXO Technologies
FOXO Technologies transforms the global longevity insurance industry with a next…
|
Minneapolis | 101 - 250 | $68.2M | Post Ipo Equity | 2025-06-04 |
| 50 |
MythWorx
MythWorx is an artificial general intelligence platform developing a biomimetic …
|
Dallas | 1 - 10 | $5.0M | Seed | 2025-10-01 |